){kind=logo}
Represented Liminatus Pharma LLC, a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies, in its merger with Iris Acquisition Corp.
-
Co-Chair, Life Sciences -
-
Deputy Chair, Capital Markets & Corporate
